Prognostic value of 18F-FDG PET/CT in patients with advanced or metastatic non-small-cell lung cancer treated with immune checkpoint inhibitors: A systematic review and meta-analysis

Prognostic value of 18F-FDG PET/CT in patients with advanced or metastatic non-small-cell lung cancer treated with immune checkpoint inhibitors: A systematic review and meta-analysis

PurposeThis study aimed to investigate the value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in predicting early immunotherapy response of immune checkpoint inhibitors (ICIs) in patients with advanced or metastatic non-small-cell lung cancer (NSCLC).Me...

Full description

Bibliographic Details
Main Authors: Tao Ling, Lianghui Zhang, Rui Peng, Chao Yue, Lingli Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Immunology
Subjects:
immune checkpoint inhibitor
non-small-cell lung cancer
prognosis
18F-FDG PET/CT
metabolic tumor volume
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1014063/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1014063/full

Similar Items